peptideResearch chemicalNo published human or animal studies identified for this specific acetylated analogueMarketed as a research chemical, not reviewed by any regulator
N-Acetyl SelankBenefits, Dosage & Interactions
Also known as: NA-Selank
N-Acetyl Selank (NA-Selank) is a synthetic analog of the naturally occurring human peptide Selank, which itself is a modified form of tuftsin, an immunomodulatory peptide. Like Selank, NA-Selank is investigated for potential anxiolytic, nootropic, and neuroprotective properties. Research on N-Acetyl Selank focuses on cognition and mood.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Insufficient — No primary literature attached to this entry yet.
Evidence strengthInsufficient — nothing graded yet
PreclinicalStrong human evidence
No primary literature attached to this entry yet.
Plasma half-life
Not established
Typical timing
morning
Default unit
mg
How to track N-Acetyl Selank doses
N-Acetyl Selank is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so N-Acetyl Selank is stored as a concentration rather than a guess. DoseRoutine converts that into mg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mg and the frequency (typical timing: morning). Cycled protocols get a start and end date so the history stays accurate when N-Acetyl Selank comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review N-Acetyl Selank alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
References & Evidence
Sources on this page that document N-Acetyl Selank dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is N-Acetyl Selank studied for?
What is N-Acetyl Selank?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
N-Acetyl Selank (NA-Selank) is a synthetic analog of the naturally occurring human peptide Selank, which itself is a modified form of tuftsin, an immunomodulatory peptide. Like Selank, NA-Selank is investigated for potential anxiolytic, nootropic, and neuroprotective properties. The N-acetyl modification is believed by some researchers to enhance the peptide's metabolic stability and bioavailability compared to its parent compound, Selank, potentially leading to a more prolonged or pronounced effect by protecting it from enzymatic degradation, though definitive human data on this specific aspect are limited (PubChem).
Selank, and by extension NA-Selank, is thought to interact with the body's endogenous regulatory systems, particularly those involved in stress response and cognitive function. It is not currently approved by regulatory bodies like the FDA for medical use in most Western countries, and its use is primarily within research contexts or as a compounded substance. Information regarding NA-Selank specifically is less extensive than for Selank, often relying on extrapolations from Selank research.
What does the research say about N-Acetyl Selank?
Tap a section to expand.
The proposed mechanisms of action for N-Acetyl Selank are largely extrapolated from research on its parent peptide, Selank, and involve interactions with several neurochemical systems. Key mechanisms under investigation include:
* **Modulation of GABAergic System:** Selank, and potentially NA-Selank, is thought to influence the levels and activity of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the central nervous system. This interaction is believed to contribute to its observed anxiolytic effects by promoting neural calm (Examine.com).
* **Impact on Monoamine Neurotransmitters:** Research suggests Selank may modulate the activity of monoamine neurotransmitters such as serotonin, dopamine, and norepinephrine in various brain regions. These neurotransmitters play crucial roles in mood regulation, cognition, and stress response (DrugBank).
* **Influence on Endogenous Regulatory Peptides:** Selank is a derivative of tuftsin. It is believed to interact with and modulate the activity of other endogenous regulatory peptides in the brain, which are involved in a wide array of physiological processes, including immunity and neuroprotection.
* **Neurotrophic Effects:** Some studies imply that Selank may exhibit neurotrophic properties, potentially supporting neuronal survival, growth, and synaptic plasticity. This could contribute to its nootropic and neuroprotective potential (NIH ODS).
* **Antioxidant Activity:** There is some evidence, though limited, to suggest that peptides like Selank may possess antioxidant properties, which could help protect brain cells from oxidative stress and contribute to overall neuroprotection.
The N-acetyl modification is hypothesized to improve the stability of the peptide against enzymatic degradation, potentially leading to a longer duration of action or increased effectiveness by enhancing its pharmacokinetics. However, specific human pharmacokinetic data for N-Acetyl Selank demonstrating these advantages over Selank are not yet broadly established in peer-reviewed literature.
Source for this section: Sources for How does N-Acetyl Selank work?: Jumps to this entry in the sources and references list at the end of the page.
N-Acetyl Selank is investigated for a range of potential benefits, largely mirroring those attributed to its base compound, Selank. These potential benefits are primarily derived from preclinical research and limited clinical studies, often conducted outside of Western regulatory frameworks.
Potential benefits under investigation include:
* **Anxiolytic Effects:** The most commonly studied potential benefit is its capacity to reduce anxiety levels without significant sedative side effects often associated with traditional anxiolytics. This effect is thought to be mediated through its presumed modulation of GABAergic systems (Examine.com).
* **Nootropic and Cognitive Enhancement:** Researchers are exploring NA-Selank's potential to improve cognitive functions such as memory, attention, and learning — especially under stressful conditions. This could stem from its purported neurotrophic and neurotransmitter modulatory effects (PubChem).
* **Neuroprotective Properties:** Animal studies suggest Selank may offer protection against neural damage caused by various stressors, including oxidative stress and ischemia. If applicable to NA-Selank, this could have implications for neurological health and recovery (DrugBank).
* **Mood Improvement:** Due to its influence on monoamine neurotransmitters like serotonin and dopamine, NA-Selank is hypothesized to contribute to improved mood and emotional stability, potentially alleviating symptoms associated with mild depression or psychological distress (NIH ODS).
* **Immune System Modulation:** Given its origin from the immunomodulatory peptide tuftsin, Selank and potentially NA-Selank, may also play a role in modulating immune responses, though this area is less extensively researched in the context of its central nervous system effects.
It is important to note that these potential benefits require more robust clinical research in humans to be definitively established and are not recognized as medical claims by major regulatory bodies.
The evidence base for N-Acetyl Selank is primarily extrapolated from studies on its parent compound, Selank. Research often involves animal models and has mainly originated from Russian scientific institutions. While promising, the current body of evidence is not yet considered robust enough by Western regulatory standards to warrant widespread clinical use.
* **Anxiolytic Efficacy:** Numerous animal studies and some human trials have investigated Selank's anxiolytic properties. For example, research published in journals indexed by PubChem suggests that Selank can reduce anxiety-like behaviors in rodents. Human studies, though often small and not subject to rigorous double-blind, placebo-controlled protocols typical in Western drug development, have also reported reductions in anxiety symptoms in individuals with generalized anxiety disorder (GABA modulation is a proposed mechanism, per Examine.com). However, specific studies on N-Acetyl Selank robustly demonstrating superior or distinct anxiolytic effects in humans compared to Selank are limited.
* **Nootropic and Neuroprotective Potential:** Evidence from animal models indicates that Selank may enhance cognitive processes like learning and memory, especially under conditions of stress or cognitive impairment. Some studies, referenced by DrugBank, explored its neuroprotective role against neuronal damage. The N-acetyl modification is theorized to enhance these effects by improving metabolic stability, but direct comparative human evidence is scarce.
* **Pharmacokinetics and Bioavailability:** The N-acetyl modification is primarily theorized to improve pharmacokinetic properties such as resistance to enzymatic degradation and potentially oral bioavailability. However, definitive human pharmacokinetic studies specifically comparing N-Acetyl Selank to Selank with robust data are limited in the publicly accessible scientific literature. Most discussions regarding its improved half-life remain theoretical or based on indirect evidence (NIH ODS).
* **Safety and Tolerability:** Clinical data on Selank, generally indicates a favorable safety profile with minimal side effects reported in the studies conducted. However, the long-term safety data and the safety profile of N-Acetyl Selank specifically are less thoroughly documented, particularly in large-scale, long-duration human trials required for regulatory approval (Mayo Clinic).
In summary, while the conceptual basis for N-Acetyl Selank's effects is derived from substantial research on Selank, robust, independent, large-scale clinical trials specifically on N-Acetyl Selank are needed to confirm proposed benefits and establish its safety and efficacy for broad therapeutic applications.
Based on research regarding Selank, the parent compound, N-Acetyl Selank is generally considered to have a favorable safety profile with minimal reported side effects in most studies. However, the specific safety data for N-Acetyl Selank is less extensive than for Selank itself, and long-term effects remain largely unstudied.
Potential side effects, primarily extrapolated from Selank research, may include:
* **Mild local irritation:** If administered via nasal spray, some individuals might experience mild irritation, dryness, or a tingling sensation in the nasal passages (PubChem).
* **Headache:** Infrequent reports of mild headaches have been noted in some Selank studies (Examine.com).
* **Fatigue or Drowsiness:** While generally considered non-sedating, some individuals might experience mild fatigue or drowsiness, particularly at higher doses, though this is not a common finding.
* **Gastrointestinal upset:** Very rarely, mild digestive issues such as nausea or stomach discomfort could occur.
* **Allergic reactions:** As with any peptide, there is a theoretical risk of allergic reaction, though reports specific to Selank or N-Acetyl Selank are rare. Symptoms could include rash, itching, or swelling.
It is important to note that the available clinical data on Selank, and by extension N-Acetyl Selank, often comes from smaller studies, and the full spectrum of potential side effects, particularly in diverse populations or with long-term use, has not been exhaustively characterized by major regulatory bodies. If any unusual or concerning symptoms occur, medical attention should be sought. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
The information regarding N-Acetyl Selank is largely based on preclinical research and limited human studies on its parent compound, Selank. Due to its status as a research peptide without broad regulatory approval, several warnings apply:
* **Lack of Regulatory Approval:** N-Acetyl Selank is not approved by major regulatory bodies such as the FDA (United States) or EMA (Europe) for any medical indications. Its quality, purity, and safety outside of a research setting cannot be assured (PubChem).
* **Limited Human Data:** While Selank has been studied for several decades, specific robust, large-scale, double-blind, placebo-controlled clinical trials on N-Acetyl Selank demonstrating its efficacy and long-term safety in diverse human populations are lacking.
* **Potential for Interactions:** Although not well-documented, N-Acetyl Selank could theoretically interact with other medications, supplements, or substances that affect the central nervous system, particularly those influencing GABAergic or monoaminergic systems. Caution is advised when combining it with anxiolytics, antidepressants, or sedatives (Mayo Clinic).
* **Individual Variability:** Responses to peptides can vary significantly among individuals due to genetic factors, health status, and other medications. What is well-tolerated by one person may not be by another.
* **Not for Self-Medication:** Due to the limited understanding of its full effects and lack of regulatory oversight, N-Acetyl Selank should not be used for self-treating medical conditions. Any health concerns should be discussed with a healthcare professional.
* **Use in Specific Populations:** Information on the safety and effects of N-Acetyl Selank in pregnant or breastfeeding women, children, or individuals with pre-existing medical conditions (e.g., liver or kidney disease, neurological disorders) is scarce. Therefore, its use in these populations is generally not recommended.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Due to the limited research and lack of comprehensive safety data for N-Acetyl Selank, particularly from large-scale human clinical trials, specific contraindications are not fully established. However, based on general principles for novel compounds and extrapolation from other peptides, the following conditions or situations should be considered potential contraindications, or warrant extreme caution and medical consultation:
* **Pregnancy and Breastfeeding:** There is no adequate data on the safety of N-Acetyl Selank during pregnancy or lactation. Therefore, it is contraindicated in these populations due to potential unknown risks to the fetus or infant (NIH ODS).
* **Children and Adolescents:** The safety and efficacy of N-Acetyl Selank have not been established in pediatric populations. Its use in individuals under the age of 18 is generally contraindicated.
* **Known Allergy or Hypersensitivity:** Individuals with a known allergy or hypersensitivity to peptides, specifically to Selank or its derivatives, should avoid N-Acetyl Selank.
* **Severe Psychiatric Conditions:** While investigated for anxiety, individuals with severe psychiatric disorders (e.g., psychosis, severe depression with suicidal ideation, bipolar disorder) should not use N-Acetyl Selank without strict medical supervision, as its effects on complex mental health conditions are not fully understood and could potentially exacerbate symptoms or interfere with prescribed treatments.
* **Co-administration with CNS Depressants:** Extreme caution is advised when considering N-Acetyl Selank alongside other central nervous system depressants (e.g., alcohol, benzodiazepines, opioids), due to the theoretical risk of additive sedating effects, although such interactions are not formally documented for N-Acetyl Selank (Mayo Clinic).
* **Serious Medical Conditions:** Individuals with severe liver, kidney, cardiovascular, or neurological diseases should exercise extreme caution, as the impact of N-Acetyl Selank on these systems is not well-characterized (DrugBank).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Given the limited research on N-Acetyl Selank, especially concerning drug-drug interactions, a cautious approach is warranted when considering its co-administration with other substances. The following categories of compounds should be approached with extreme caution or avoided unless specifically directed by a licensed clinician:
* **Alcohol:** Combining N-Acetyl Selank with alcohol is generally not recommended. While N-Acetyl Selank is not typically described as sedating, alcohol is a central nervous system (CNS) depressant, and there's a theoretical risk of additive effects, potentially leading to increased drowsiness, impaired coordination, or other adverse reactions (Examine.com).
* **Benzodiazepines and other Anxiolytics/Sedatives:** Since N-Acetyl Selank is purported to have anxiolytic properties, combining it with prescription anxiolytics (e.g., Xanax, Valium, Klonopin) or other sedatives could lead to excessive CNS depression. This could result in increased drowsiness, dizziness, impaired cognitive function, and potentially respiratory depression (Mayo Clinic).
* **Antidepressants (SSRIs, SNRIs, TCAs, MAOIs):** N-Acetyl Selank is believed to modulate monoamine neurotransmitters. Combining it with antidepressant medications that also affect serotonin, norepinephrine, or dopamine levels could theoretically lead to an imbalance in these neurotransmitters, potentially causing side effects (e.g., serotonin syndrome with SSRIs) or altering the efficacy of either substance. Specific interaction data is lacking, making caution paramount (PubChem).
* **Opioid Pain Medications:** Like other CNS depressants, opioids can cause sedation and respiratory depression. Combining them with N-Acetyl Selank could theoretically exacerbate these effects, increasing risks (NIH ODS).
* **Immunosuppressants:** Given that Selank is a derivative of tuftsin, an immunomodulatory peptide, there is a theoretical, albeit unproven, concern that N-Acetyl Selank could influence immune function. Therefore, combining it with immunosuppressant drugs could potentially interfere with their intended effects.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
N-Acetyl Selank is commonly studied with a "morning" administration. The N-acetyl modification is hypothesized to improve the peptide's metabolic stability and potentially prolong its presence and activity in the body compared to its parent compound, Selank. This theoretical extended action might make a single daily dose, often in the morning, practical for maintaining desired effects throughout the day.
The reason for morning administration often relates to its purported anxiolytic and nootropic potential. Taking it in the morning aligns with periods of daily activity and demands on cognitive function, where its effects on focus, mood, and stress reduction might be most beneficial. While some compounds are affected by food intake, N-Acetyl Selank is generally regarded as being able to be taken "either" with or without food.
However, individual needs and responses can vary significantly. Some individuals might find benefit from differing administration schedules based on personal response and the specific goal of use. Dose is user-directed and must be set by a licensed clinician. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Source for this section: Sources for When should you take N-Acetyl Selank?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with N-Acetyl Selank?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about N-Acetyl Selank
N-Acetyl Selank (NA-Selank) is a synthetic research peptide derived from Selank, which itself is an analog of the naturally occurring human peptide tuftsin. The N-acetyl modification is believed to enhance its stability and bioavailability, and it is investigated for potential anxiolytic, nootropic, and neuroprotective properties.
The primary difference lies in the N-acetyl group attached to the peptide. This modification is theorized to improve the peptide's metabolic stability and resistance to enzymatic degradation, potentially leading to a longer duration of action or increased effectiveness. However, definitive human clinical evidence directly comparing the pharmacokinetics and efficacy of N-Acetyl Selank versus Selank is limited.
Researchers are exploring N-Acetyl Selank for potential benefits including reduction of anxiety, improvement of cognitive functions like memory and attention, neuroprotection, and mood enhancement. These benefits are largely extrapolated from studies on Selank and require more extensive human clinical trials to be fully confirmed (Examine.com).
Based on research for Selank, N-Acetyl Selank is generally considered to have a favorable safety profile with minimal reported side effects, which may include mild nasal irritation (if administered nasally), headache, or very rarely, mild fatigue. Long-term safety data for N-Acetyl Selank specifically is not yet robust. (PubChem) This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
No, N-Acetyl Selank is not approved by major regulatory bodies such as the FDA or EMA for any medical uses. Its use is primarily within research settings, and it is not available as a prescription medication in most Western countries. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Interaction risk for N-Acetyl Selank comes from the rest of the stack: other peptides, prescription medicines, hormone therapy and peptides. Because N-Acetyl Selank is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers N-Acetyl Selank with no sign-up.
N-Acetyl Selank is typically taken in the morning. Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.
There is no single answer for N-Acetyl Selank plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing N-Acetyl Selank with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for N-Acetyl Selank varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of N-Acetyl Selank depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For N-Acetyl Selank the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 133082488(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/133082488
Verify at
Publisher search links for N-Acetyl Selank. These are places to check the information — they are not citations, so they are not numbered.
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on N-Acetyl Selank?
Plain-text summary, safe to quote verbatim:
N-Acetyl Selank (NA-Selank) is a synthetic analog of the naturally occurring human peptide Selank, which itself is a modified form of tuftsin, an immunomodulatory peptide. Like Selank, NA-Selank is investigated for potential anxiolytic, nootropic, and neuroprotective properties. Research on N-Acetyl Selank focuses on cognition and mood.
Source: DoseRoutine — https://doseroutine.com/library/n-acetyl-selank
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). N-Acetyl Selank — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/n-acetyl-selank
What compounds are similar to N-Acetyl Selank?
Others in the peptide category or studied for the same goals.
Which goals is N-Acetyl Selank used for?
Other compounds studied for the same benefits as N-Acetyl Selank.
Continue exploring
See every compound DoseRoutine catalogs for these goals.